For the entire healthcare sector? Maybe. For pharmaceutical companies? In comparison to a liability-free, recurring subscription, mandated by the federal gover

For the entire healthcare sector? Maybe. For pharmaceutical companies? In comparison to a liability-free, recurring subscription, mandated by the federal government for hundreds of millions? Not so much.